Joshi Mehul
- SEC CIK
- 0001939602
No open-market purchases or sales filed in the past year.
Current role at each company
- LUNG Pulmonx CorpChief Financial Officer & PAOas of Sep 3, 2025
- CELL Bruker Cellular Analysis, Inc.Chief Financial Officeras of Oct 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Joshi Mehul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LUNG Pulmonx Corp
Chief Financial Officer & PAO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 (view filing) | Sep 2 | 1 day | Joshi MehulChief Financial Officer & PAO | SSale | −7.94K | $1.60 | −$12.7K | −3.7%208.5K after | 2 lots |
| Jun 4, 2025 (view filing) | Jun 2 | 2 days | Joshi MehulChief Financial Officer & PAO | SSale | −8.06K | $3.13 | −$25.2K | −3.6%213.9K after | 2 lots |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Joshi MehulChief Financial Officer & PAO | SSale | −14.4K | $7.12 | −$102.4K | −11.2%114.0K after |